ロード中...
Impact of bosentan on health-related quality of life and dyspnoea in idiopathic pulmonary fibrosis: the BUILD-1 trial
OBJECTIVE: No therapy is known to improve health-related quality of life (HRQL) or dyspnoea in patients with idiopathic pulmonary fibrosis (IPF). This study investigated longitudinal changes in HRQL and dyspnoea and explored the effects of bosentan on these endpoints during the BUILD-1 trial. METHOD...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2848824/ https://ncbi.nlm.nih.gov/pubmed/19679600 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/09031936.00188108 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|